Actively Recruiting
Identify microRNAs in Cachexia in Pancreatic Carcinoma
Led by University of Oklahoma · Updated on 2026-01-08
100
Participants Needed
1
Research Sites
333 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to determine the proportion of pancreatic patients who experience weight loss and cachexia, and to identify any differences in the genes between patient groups.
CONDITIONS
Official Title
Identify microRNAs in Cachexia in Pancreatic Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patient 18 years or older at the time of consent
- Operable pancreatic tumors diagnosed within the last 12 months
- Diagnosis confirmed as pancreatic adenocarcinoma by clinical or pathology criteria
- Stage I or higher pancreatic cancer considered suitable for surgical removal, with or without prior chemotherapy
- Ability to provide written informed consent and HIPAA authorization
You will not qualify if you...
- Patients with pancreatic adenocarcinoma not eligible for surgical removal
- Patients diagnosed with any cancer other than primary pancreatic adenocarcinoma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stephenson Cancer Center
Oklahoma City, Oklahoma, United States, 73117
Actively Recruiting
Research Team
L
Lead Nurse
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here